Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 11, 2022
Total Value: $1.658B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Instil Bio Inc | 12,486,787 | $214M | 12.9% | $25.08 | — | Common | 45783C101 |
| HRMY | Harmony Biosciences Holdings Inc | 4,884,341 | $208M | 12.6% | $36.16 | +10.2% | Common | 413197104 |
| — | New Frontier Health Corp | 14,300,000 | $164M | 9.9% | $8.25 | — | Ord Shs | G6461G106 |
| — | Iveric Bio Inc | 6,290,827 | $105M | 6.3% | $5.70 | — | Common | 46583P102 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $90.69M | 5.5% | $39.31 | +9.7% | Common | 00166B105 |
| TARS | Tarsus Pharmaceuticals Inc | 2,987,331 | $67.22M | 4.1% | $28.48 | -8.7% | Common | 87650L103 |
| — | Amyris, Inc | 11,642,195 | $62.98M | 3.8% | $3.12 | — | Common | 03236M200 |
| ASND | Ascendis Pharma A/S | 442,502 | $59.53M | 3.6% | $112.61 | — | SPONSORED ADR | 04351P101 |
| — | Aligos Therapeutics Inc | 3,547,030 | $42.1M | 2.5% | $27.65 | — | Common | 01626L105 |
| — | Sierra Oncology, Inc | 1,917,074 | $41.68M | 2.5% | $10.67 | — | Common | 82640U404 |
| — | Genetron Holdings Ltd | 6,339,860 | $38.67M | 2.3% | $12.07 | — | ADS | 37186H100 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 2.3% | $6.47 | 0.0% | SHS | P8696W104 |
| VTYX | Ventyx Biosciences Inc | 1,791,275 | $35.58M | 2.1% | $18.95 | 0.0% | Common | 92332V107 |
| WHWK | Aadi Bioscience Inc | 1,303,390 | $31.48M | 1.9% | $30.48 | -17.6% | Common | 00032Q104 |
| VRDN | Viridian Therapeutics Inc | 1,300,000 | $25.7M | 1.5% | $14.67 | +27.0% | Common | 92790C104 |
| — | Impel NeuroPharma Inc | 2,884,789 | $24.9M | 1.5% | $8.85 | — | Common | 45258K109 |
| — | Avadel Pharmaceuticals PLC | 2,937,093 | $23.73M | 1.4% | $7.94 | — | ADR | 05337M104 |
| KALV | KalVista Pharmaceuticals Inc. | 1,533,559 | $20.29M | 1.2% | $15.45 | +3.0% | Common | 483497103 |
| RLMD | Relmada Therapeutics Inc | 882,352 | $19.88M | 1.2% | $22.24 | 0.0% | Common | 75955J402 |
| IOBT | IO Biotech Inc | 3,015,545 | $19.3M | 1.2% | $9.66 | 0.0% | Common | 449778109 |
| — | Bolt Therapeutics Inc | 3,871,291 | $18.97M | 1.1% | $32.91 | — | Common | 097702104 |
| TERN | Terns Pharmaceuticals Inc | 2,675,133 | $18.91M | 1.1% | $21.92 | -62.0% | Common | 880881107 |
| CLDX | Celldex Therapeutics Inc | 484,453 | $18.72M | 1.1% | $4.95 | +780.4% | Common | 15117B202 |
| — | Verona Pharma PLC | 2,749,918 | $18.48M | 1.1% | $5.20 | — | ADS | 925050106 |
| COGT | Cogent Biosciences Inc | 1,920,941 | $16.48M | 1.0% | $7.93 | +9.6% | Common | 19240Q201 |
| OLMA | Olema Pharmaceuticals Inc | 1,689,515 | $15.81M | 1.0% | $39.90 | -48.1% | Common | 68062P106 |
| — | Chinook Therapeutics Inc | 872,151 | $14.22M | 0.9% | $15.86 | — | Common | 16961L106 |
| — | Merus NV | 442,000 | $14.06M | 0.8% | $21.00 | — | Common | N5749R100 |
| ACRS | Aclaris Therapeutics, Inc. | 920,982 | $13.39M | 0.8% | $1.36 | +1013.0% | Common | 00461U105 |
| SERA | Sera Prognostics Inc | 1,856,011 | $12.75M | 0.8% | $10.38 | -3.2% | Common | 81749D107 |
| CDXS | Codexis, Inc | 388,144 | $12.14M | 0.7% | $13.98 | +135.3% | Common | 192005106 |
| LEGN | Legend Biotech Corp Sponsored | 244,375 | $11.39M | 0.7% | $42.56 | — | SPONSORED ADS | 52490G102 |
| — | Minerva Surgical Inc | 2,215,667 | $11.39M | 0.7% | $5.14 | — | Common | 60343F106 |
| DSGN | Design Therapeutics | 530,991 | $11.37M | 0.7% | $31.14 | -44.9% | Common | 25056L103 |
| MREO | Mereo Biopharma Group PLC | 6,907,189 | $11.05M | 0.7% | $2.58 | — | ADS | 589492107 |
| ZLAB | Zai Lab Ltd ADR | 174,999 | $11M | 0.7% | $76.83 | — | ADR | 98887Q104 |
| — | Essa Pharma Inc | 744,058 | $10.57M | 0.6% | $9.69 | — | Common | 29668H708 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $9.11M | 0.5% | $40.33 | +70.4% | Common | 04280A100 |
| — | Dice Therapeutics Inc | 326,272 | $8.258M | 0.5% | $32.75 | — | Common | 23345J104 |
| — | Bellus Health Inc | 1,017,152 | $8.188M | 0.5% | $8.05 | — | Common | 07987C204 |
| NKTX | Nkarta Inc | 512,225 | $7.863M | 0.5% | $29.47 | -41.8% | Common | 65487U108 |
| DYN | Dyne Therapeutics Inc | 577,642 | $6.868M | 0.4% | $20.78 | -32.4% | Common | 26818M108 |
| CMPX | Compass Therapeutics Inc | 2,000,000 | $6.34M | 0.4% | $3.29 | 0.0% | Common | 20454B104 |
| — | Gracell Biotechnologies Inc | 961,359 | $5.807M | 0.4% | $15.40 | — | SPONSORED ADS | 38406L103 |
| IOVA | Iovance Biotherapeutics Inc | 301,000 | $5.746M | 0.3% | $22.02 | 0.0% | Common | 462260100 |
| — | Satsuma Pharmaceuticals Inc | 1,232,394 | $5.546M | 0.3% | $5.91 | — | Common | 80405P107 |
| — | Zymeworks Inc | 286,064 | $4.689M | 0.3% | $35.47 | — | Common | 98985W102 |
| LRMR | Larimar Therapeutics Inc | 399,830 | $4.314M | 0.3% | $11.65 | -4.5% | Common | 517125100 |
| — | Aslan Pharmaceuticals Ltd | 2,840,909 | $3.182M | 0.2% | $3.35 | — | ADS | 04522R101 |
| — | Homology Medicines, Inc. | 853,143 | $3.105M | 0.2% | $15.54 | — | Common | 438083107 |
| — | Elevation Oncology Inc | 496,844 | $2.991M | 0.2% | $13.57 | — | Common | 28623U101 |
| — | Zogenix Inc | 105,000 | $1.706M | 0.1% | $22.77 | — | Common | 98978L204 |
| — | Precision Biosciences Inc | 140,255 | $1.038M | 0.1% | $6.03 | — | Common | 74019P108 |
| — | Metacrine Inc | 146,426 | $99,000 | 0.0% | $10.21 | — | Common | 59101E103 |
| — | Eiger BioPharmaceuticals Inc | 4,166 | $22,000 | 0.0% | $6.80 | — | Common | 28249U105 |